264 related articles for article (PubMed ID: 22104201)
21. Helicobacter pylori infection and gastric cancer.
Matysiak-Budnik T; Mégraud F
Eur J Cancer; 2006 Apr; 42(6):708-16. PubMed ID: 16556496
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
23. Genetic and epigenetic alteration in gastric carcinogenesis.
Resende C; Ristimäki A; Machado JC
Helicobacter; 2010 Sep; 15 Suppl 1():34-9. PubMed ID: 21054651
[TBL] [Abstract][Full Text] [Related]
24. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach.
van Rees BP; Musler A; Caspers E; Drillenburg P; Craanen ME; Polkowski W; Chibowski D; Offerhaus GJ
Hepatogastroenterology; 1999; 46(27):2063-8. PubMed ID: 10430398
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese.
Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC
Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334
[TBL] [Abstract][Full Text] [Related]
26. Gastric cancer: basic aspects.
Resende C; Thiel A; Machado JC; Ristimäki A
Helicobacter; 2011 Sep; 16 Suppl 1():38-44. PubMed ID: 21896084
[TBL] [Abstract][Full Text] [Related]
27. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
[TBL] [Abstract][Full Text] [Related]
28. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
30. [Genetic and epigenetic alterations in gastric carcinogenesis].
Ushijima T; Yoshida S
Nihon Rinsho; 2012 Oct; 70(10):1705-14. PubMed ID: 23198549
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis.
Milne AN; Sitarz R; Carvalho R; Polak MM; Ligtenberg M; Pauwels P; Offerhaus GJ; Weterman MA
Hum Pathol; 2007 Jun; 38(6):903-13. PubMed ID: 17376510
[TBL] [Abstract][Full Text] [Related]
32. New concepts of molecular biology on gastric carcinogenesis.
Kountouras J; Zavos C; Chatzopoulos D
Hepatogastroenterology; 2005; 52(64):1305-12. PubMed ID: 16001683
[TBL] [Abstract][Full Text] [Related]
33. Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China.
Huang L; Zhang KL; Li H; Chen XY; Kong QY; Sun Y; Gao X; Guan HW; Liu J
Hum Pathol; 2006 Dec; 37(12):1557-67. PubMed ID: 16949912
[TBL] [Abstract][Full Text] [Related]
34. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses.
Fox JG; Sheppard BJ; Dangler CA; Whary MT; Ihrig M; Wang TC
Cancer Res; 2002 Feb; 62(3):696-702. PubMed ID: 11830522
[TBL] [Abstract][Full Text] [Related]
35. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation as a molecular biomarker in gastric cancer.
Tahara T; Arisawa T
Epigenomics; 2015; 7(3):475-86. PubMed ID: 26077432
[TBL] [Abstract][Full Text] [Related]
37. Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions.
David S; Meltzer SJ
Cancer Biomark; 2010; 9(1-6):493-507. PubMed ID: 22112492
[TBL] [Abstract][Full Text] [Related]
38. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis.
Nardone G; Compare D; De Colibus P; de Nucci G; Rocco A
Dig Dis; 2007; 25(3):225-9. PubMed ID: 17827945
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
